An Approach to Assess Quality of Life Through Biometric Monitoring in Cancer Patients
暂无分享,去创建一个
Luís Paulo Reis | Joaquim Gonçalves | Brígida Mónica Faria | Jorge Oliveira e Sá | Luis Paulo Reis | Alexandra Oliveira | Victor Carvalho | B. M. Faria | Eliana Silva | Joyce Aguiar | E. Silva | Joyce Aguiar | Joaquim Gonçalves | Victor Carvalho | Alexandra Oliveira
[1] Tony Reiman,et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Ebrahim,et al. Clinical and public health perspectives and applications of health-related quality of life measurement. , 1995, Social science & medicine.
[3] A. Kuntz,et al. The Autonomic Nervous System , 1958 .
[4] Ashley Leak,et al. Quality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review , 2011, Leukemia & lymphoma.
[5] Ursula Wolf,et al. Heart Rate Variability as a Prognostic Factor for Cancer Survival – A Systematic Review , 2018, Front. Physiol..
[6] Kendra Schwartz,et al. Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988–2008) , 2012, SpringerPlus.
[7] Joaquim Goncalves,et al. Data mining and electronic devices applied to quality of life related to health data , 2015, 2015 10th Iberian Conference on Information Systems and Technologies (CISTI).
[8] I-Mei Lin,et al. Methodological issues in measuring health-related quality of life , 2013 .
[9] Joaquim Goncalves,et al. QVida+: Quality of life continuos estimation for clinical decision support , 2016, 2016 11th Iberian Conference on Information Systems and Technologies (CISTI).
[10] Nazneen Akhter,et al. Heart Rate Variability for Biometric Authentication Using Time-Domain Features , 2015, SSCC.
[11] Steven Piantadosi,et al. Wearable activity monitors in oncology trials: Current use of an emerging technology. , 2018, Contemporary clinical trials.
[12] Sean Khozin,et al. Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem , 2017, Nature Reviews Drug Discovery.
[13] F. Shaffer,et al. An Overview of Heart Rate Variability Metrics and Norms , 2017, Front. Public Health.
[14] Josef Kautzner,et al. Clinical relevance of heart rate variability , 1997, Clinical cardiology.
[15] Polyana Figueiredo Fernandes Lopes,et al. Aplicabilidade Clínica da Variabilidade da Frequência Cardíaca , 2014 .
[16] Julia Dürner,et al. Individual quality of life in patients with multiple myeloma , 2013, SpringerPlus.
[17] David Cella,et al. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation , 2003, Health and quality of life outcomes.
[18] David Cella,et al. The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym) , 2013 .
[19] David Cella,et al. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy – Lymphoma Symptom Index , 2013, Leukemia and Lymphoma.
[20] Jesús María Rodríguez Presedo,et al. Heart Rate Variability Analysis with the R package RHRV , 2017 .